BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liao HW, Hsu JM, Xia W, Wang HL, Wang YN, Chang WC, Arold ST, Chou CK, Tsou PH, Yamaguchi H, Fang YF, Lee HJ, Lee HH, Tai SK, Yang MH, Morelli MP, Sen M, Ladbury JE, Chen CH, Grandis JR, Kopetz S, Hung MC. PRMT1-mediated methylation of the EGF receptor regulates signaling and cetuximab response. J Clin Invest. 2015;125:4529-4543. [PMID: 26571401 DOI: 10.1172/jci82826] [Cited by in Crossref: 70] [Cited by in F6Publishing: 50] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhao J, Adams A, Roberts B, O'Neil M, Vittal A, Schmitt T, Kumer S, Cox J, Li Z, Weinman SA, Tikhanovich I. Protein arginine methyl transferase 1- and Jumonji C domain-containing protein 6-dependent arginine methylation regulate hepatocyte nuclear factor 4 alpha expression and hepatocyte proliferation in mice. Hepatology 2018;67:1109-26. [PMID: 29023917 DOI: 10.1002/hep.29587] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
2 Li J, Ma X, Chakravarti D, Shalapour S, DePinho RA. Genetic and biological hallmarks of colorectal cancer. Genes Dev 2021;35:787-820. [PMID: 34074695 DOI: 10.1101/gad.348226.120] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Marsden AJ, Riley DRJ, Barry A, Khalil JS, Guinn BA, Kemp NT, Rivero F, Beltran-Alvarez P. Inhibition of Arginine Methylation Impairs Platelet Function. ACS Pharmacol Transl Sci 2021;4:1567-77. [PMID: 34661075 DOI: 10.1021/acsptsci.1c00135] [Reference Citation Analysis]
4 Singh B, Carpenter G, Coffey RJ. EGF receptor ligands: recent advances. F1000Res 2016;5:F1000 Faculty Rev-2270. [PMID: 27635238 DOI: 10.12688/f1000research.9025.1] [Cited by in Crossref: 102] [Cited by in F6Publishing: 84] [Article Influence: 17.0] [Reference Citation Analysis]
5 Chou CK, Liu YL, Chen YI, Huang PJ, Tsou PH, Chen CT, Lee HH, Wang YN, Hsu JL, Lee JF, Yankeelov TE, Kameoka J, Yeh HC, Hung MC. Digital Receptor Occupancy Assay in Quantifying On- and Off-Target Binding Affinities of Therapeutic Antibodies. ACS Sens 2020;5:296-302. [PMID: 32073836 DOI: 10.1021/acssensors.9b01736] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Yao B, Gui T, Zeng X, Deng Y, Wang Z, Wang Y, Yang D, Li Q, Xu P, Hu R, Li X, Chen B, Wang J, Zen K, Li H, Davis MJ, Herold MJ, Pan HF, Jiang ZW, Huang DCS, Liu M, Ju J, Zhao Q. PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling. Genome Med 2021;13:58. [PMID: 33853662 DOI: 10.1186/s13073-021-00871-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ryu TY, Kim K, Son MY, Min JK, Kim J, Han TS, Kim DS, Cho HS. Downregulation of PRMT1, a histone arginine methyltransferase, by sodium propionate induces cell apoptosis in colon cancer. Oncol Rep 2019;41:1691-9. [PMID: 30569144 DOI: 10.3892/or.2018.6938] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
8 Hsu JL, Hung MC. The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer. Cancer Metastasis Rev 2016;35:575-88. [PMID: 27913999 DOI: 10.1007/s10555-016-9649-6] [Cited by in Crossref: 94] [Cited by in F6Publishing: 88] [Article Influence: 18.8] [Reference Citation Analysis]
9 Katsuno Y, Qin J, Oses-Prieto J, Wang H, Jackson-Weaver O, Zhang T, Lamouille S, Wu J, Burlingame A, Xu J, Derynck R. Arginine methylation of SMAD7 by PRMT1 in TGF-β-induced epithelial-mesenchymal transition and epithelial stem-cell generation. J Biol Chem 2018;293:13059-72. [PMID: 29907569 DOI: 10.1074/jbc.RA118.002027] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 9.3] [Reference Citation Analysis]
10 Zhou J, Ji Q, Li Q. Resistance to anti-EGFR therapies in metastatic colorectal cancer: underlying mechanisms and reversal strategies. J Exp Clin Cancer Res 2021;40:328. [PMID: 34663410 DOI: 10.1186/s13046-021-02130-2] [Reference Citation Analysis]
11 Zheng NN, Zhou M, Sun F, Huai MX, Zhang Y, Qu CY, Shen F, Xu LM. Combining protein arginine methyltransferase inhibitor and anti-programmed death-ligand-1 inhibits pancreatic cancer progression. World J Gastroenterol 2020; 26(26): 3737-3749 [PMID: 32774054 DOI: 10.3748/wjg.v26.i26.3737] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
12 Secomandi E, Salwa A, Vidoni C, Ferraresi A, Follo C, Isidoro C. High Expression of the Lysosomal Protease Cathepsin D Confers Better Prognosis in Neuroblastoma Patients by Contrasting EGF-Induced Neuroblastoma Cell Growth. Int J Mol Sci 2022;23:4782. [PMID: 35563171 DOI: 10.3390/ijms23094782] [Reference Citation Analysis]
13 He X, Zhu Y, Lin YC, Li M, Du J, Dong H, Sun J, Zhu L, Wang H, Ding Z, Zhang L, Zhang L, Zhao D, Wang Z, Wu H, Zhang H, Jiang W, Xu Y, Jin J, Shen Y, Perry J, Zhao X, Zhang B, Liu S, Xue SL, Shen B, Chen CW, Chen J, Khaled S, Kuo YH, Marcucci G, Luo Y, Li L. PRMT1-mediated FLT3 arginine methylation promotes maintenance of FLT3-ITD+ acute myeloid leukemia. Blood 2019;134:548-60. [PMID: 31217189 DOI: 10.1182/blood.2019001282] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
14 Simpson CM, Zhang B, Hornbeck PV, Gnad F. Systematic analysis of the intersection of disease mutations with protein modifications. BMC Med Genomics 2019;12:109. [PMID: 31345222 DOI: 10.1186/s12920-019-0543-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
15 Meng X, Zhao Y, Liu J, Wang L, Dong Z, Zhang T, Gu X, Zheng Z. Comprehensive analysis of histone modification-associated genes on differential gene expression and prognosis in gastric cancer. Exp Ther Med 2019;18:2219-30. [PMID: 31452712 DOI: 10.3892/etm.2019.7808] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Saloura V, Vougiouklakis T, Zewde M, Deng X, Kiyotani K, Park JH, Matsuo Y, Lingen M, Suzuki T, Dohmae N, Hamamoto R, Nakamura Y. WHSC1L1-mediated EGFR mono-methylation enhances the cytoplasmic and nuclear oncogenic activity of EGFR in head and neck cancer. Sci Rep 2017;7:40664. [PMID: 28102297 DOI: 10.1038/srep40664] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
17 Park MJ, Han HJ, Kim DI. Lipotoxicity-Induced PRMT1 Exacerbates Mesangial Cell Apoptosis via Endoplasmic Reticulum Stress. Int J Mol Sci 2017;18:E1421. [PMID: 28671608 DOI: 10.3390/ijms18071421] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
18 Rainczuk AK, Klatt S, Yamaryo-Botté Y, Brammananth R, McConville MJ, Coppel RL, Crellin PK. MtrP, a putative methyltransferase in Corynebacteria, is required for optimal membrane transport of trehalose mycolates. J Biol Chem 2020;295:6108-19. [PMID: 32217691 DOI: 10.1074/jbc.RA119.011688] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
19 Li K, Wu JL, Qin B, Fan Z, Tang Q, Lu W, Zhang H, Xing F, Meng M, Zou S, Wei W, Chen H, Cai J, Wang H, Zhang H, Cai J, Fang L, Bian X, Chen C, Lan P, Ghesquière B, Fang L, Lee MH. ILF3 is a substrate of SPOP for regulating serine biosynthesis in colorectal cancer. Cell Res 2020;30:163-78. [PMID: 31772275 DOI: 10.1038/s41422-019-0257-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
20 Cai WQ, Zeng LS, Wang LF, Wang YY, Cheng JT, Zhang Y, Han ZW, Zhou Y, Huang SL, Wang XW, Peng XC, Xiang Y, Ma Z, Cui SZ, Xin HW. The Latest Battles Between EGFR Monoclonal Antibodies and Resistant Tumor Cells. Front Oncol 2020;10:1249. [PMID: 32793499 DOI: 10.3389/fonc.2020.01249] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 12.5] [Reference Citation Analysis]
21 Du Y, Yamaguchi H, Hsu JL, Hung M. PARP inhibitors as precision medicine for cancer treatment. National Science Review 2017;4:576-92. [DOI: 10.1093/nsr/nwx027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
22 Xu J, Chang WH, Fong LWR, Weiss RH, Yu SL, Chen CH. Targeting the insulin-like growth factor-1 receptor in MTAP-deficient renal cell carcinoma. Signal Transduct Target Ther 2019;4:2. [PMID: 30701095 DOI: 10.1038/s41392-019-0035-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
23 Choucair A, Pham TH, Omarjee S, Jacquemetton J, Kassem L, Trédan O, Rambaud J, Marangoni E, Corbo L, Treilleux I, Le Romancer M. The arginine methyltransferase PRMT1 regulates IGF-1 signaling in breast cancer.Oncogene. 2019;38:4015-4027. [PMID: 30692633 DOI: 10.1038/s41388-019-0694-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
24 Zhang J, Rojas S, Singh S, Musich PR, Gutierrez M, Yao Z, Thewke D, Jiang Y. Wnt2 Contributes to the Development of Atherosclerosis. Front Cardiovasc Med 2021;8:751720. [PMID: 34901211 DOI: 10.3389/fcvm.2021.751720] [Reference Citation Analysis]
25 Zhao J, O'Neil M, Vittal A, Weinman SA, Tikhanovich I. PRMT1-Dependent Macrophage IL-6 Production Is Required for Alcohol-Induced HCC Progression. Gene Expr 2019;19:137-50. [PMID: 30236171 DOI: 10.3727/105221618X15372014086197] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
26 Mutlu M, Mutlu P, Azarkan S, Bayır Ö, Öcal B, Saylam G, Korkmaz MH. Evaluation of Methylation Profiles of An Epidermal Growth Factor Receptor Gene in a Head and Neck Squamous Cell Carcinoma Patient Group. Balkan J Med Genet 2020;23:65-72. [PMID: 33816074 DOI: 10.2478/bjmg-2020-0025] [Reference Citation Analysis]
27 Bao J, Di Lorenzo A, Lin K, Lu Y, Zhong Y, Sebastian MM, Muller WJ, Yang Y, Bedford MT. Mouse Models of Overexpression Reveal Distinct Oncogenic Roles for Different Type I Protein Arginine Methyltransferases. Cancer Res 2019;79:21-32. [PMID: 30352814 DOI: 10.1158/0008-5472.CAN-18-1995] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.8] [Reference Citation Analysis]
28 Zhu Y, He X, Lin YC, Dong H, Zhang L, Chen X, Wang Z, Shen Y, Li M, Wang H, Sun J, Nguyen LX, Zhang H, Jiang W, Yang Y, Chen J, Müschen M, Chen CW, Konopleva MY, Sun W, Jin J, Carlesso N, Marcucci G, Luo Y, Li L. Targeting PRMT1-mediated FLT3 methylation disrupts maintenance of MLL-rearranged acute lymphoblastic leukemia. Blood 2019;134:1257-68. [PMID: 31395602 DOI: 10.1182/blood.2019002457] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
29 Suresh S, Huard S, Brisson A, Némati F, Dakroub R, Poulard C, Ye M, Martel E, Reyes C, Silvestre DC, Meseure D, Nicolas A, Gentien D, Fayyad-Kazan H, Le Romancer M, Decaudin D, Roman-Roman S, Dubois T. PRMT1 Regulates EGFR and Wnt Signaling Pathways and Is a Promising Target for Combinatorial Treatment of Breast Cancer. Cancers (Basel) 2022;14:306. [PMID: 35053470 DOI: 10.3390/cancers14020306] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Hwang JW, Cho Y, Bae GU, Kim SN, Kim YK. Protein arginine methyltransferases: promising targets for cancer therapy. Exp Mol Med 2021;53:788-808. [PMID: 34006904 DOI: 10.1038/s12276-021-00613-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
31 Vinet M, Suresh S, Maire V, Monchecourt C, Némati F, Lesage L, Pierre F, Ye M, Lescure A, Brisson A, Meseure D, Nicolas A, Rigaill G, Marangoni E, Del Nery E, Roman-Roman S, Dubois T. Protein arginine methyltransferase 5: A novel therapeutic target for triple-negative breast cancers. Cancer Med 2019;8:2414-28. [PMID: 30957988 DOI: 10.1002/cam4.2114] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
32 Li X, Zhao Z, Yi S, Ma L, Li M, Liu M, Zhang Y, Liu G. Nuclear Klf4 accumulation is associated with cetuximab drug-resistance and predicts poor prognosis of nasopharyngeal carcinoma. J Transl Med 2018;16:183. [PMID: 29973197 DOI: 10.1186/s12967-018-1561-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
33 Yin XK, Wang YL, Wang F, Feng WX, Bai SM, Zhao WW, Feng LL, Wei MB, Qin CL, Wang F, Chen ZL, Yi HJ, Huang Y, Xie PY, Kim T, Wang YN, Hou JW, Li CW, Liu Q, Fan XJ, Hung MC, Wan XB. PRMT1 enhances oncogenic arginine methylation of NONO in colorectal cancer. Oncogene 2021;40:1375-89. [PMID: 33420374 DOI: 10.1038/s41388-020-01617-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
34 Liao HW, Hung MC. Intracaecal Orthotopic Colorectal Cancer Xenograft Mouse Model. Bio Protoc 2017;7:e2311. [PMID: 29104894 DOI: 10.21769/BioProtoc.2311] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
35 Yang C, Zhang J, Ma Y, Wu C, Cui W, Wang L. Histone methyltransferase and drug resistance in cancers. J Exp Clin Cancer Res 2020;39:173. [PMID: 32859239 DOI: 10.1186/s13046-020-01682-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
36 Gou Y, Li J, Jackson-Weaver O, Wu J, Zhang T, Gupta R, Cho I, Ho TV, Chen Y, Li M, Richard S, Wang J, Chai Y, Xu J. Protein Arginine Methyltransferase PRMT1 Is Essential for Palatogenesis. J Dent Res 2018;97:1510-8. [PMID: 29986157 DOI: 10.1177/0022034518785164] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
37 Hsu WJ, Chen CH, Chang YC, Cheng CH, TsaI YH, Lin CW. PRMT1 Confers Resistance to Olaparib via Modulating MYC Signaling in Triple-Negative Breast Cancer. J Pers Med 2021;11:1009. [PMID: 34683150 DOI: 10.3390/jpm11101009] [Reference Citation Analysis]
38 Peterson JL, Ceresa BP. Epidermal Growth Factor Receptor Expression in the Corneal Epithelium. Cells 2021;10:2409. [PMID: 34572058 DOI: 10.3390/cells10092409] [Reference Citation Analysis]
39 Wang Y, Hsu JM, Kang Y, Wei Y, Lee PC, Chang SJ, Hsu YH, Hsu JL, Wang HL, Chang WC, Li CW, Liao HW, Chang SS, Xia W, Ko HW, Chou CK, Fleming JB, Wang H, Hwang RF, Chen Y, Qin J, Hung MC. Oncogenic Functions of Gli1 in Pancreatic Adenocarcinoma Are Supported by Its PRMT1-Mediated Methylation. Cancer Res. 2016;76:7049-7058. [PMID: 27758883 DOI: 10.1158/0008-5472.can-16-0715] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
40 Epstein DM, Buck E. Old dog, new tricks: extracellular domain arginine methylation regulates EGFR function. J Clin Invest 2015;125:4320-2. [PMID: 26571394 DOI: 10.1172/JCI85001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
41 Song C, Chen T, He L, Ma N, Li JA, Rong YF, Fang Y, Liu M, Xie D, Lou W. PRMT1 promotes pancreatic cancer growth and predicts poor prognosis. Cell Oncol (Dordr). 2020;43:51-62. [PMID: 31520395 DOI: 10.1007/s13402-019-00435-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
42 Al-Hamashi AA, Diaz K, Huang R. Non-Histone Arginine Methylation by Protein Arginine Methyltransferases. Curr Protein Pept Sci 2020;21:699-712. [PMID: 32379587 DOI: 10.2174/1389203721666200507091952] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
43 Poulard C, Corbo L, Le Romancer M. Protein arginine methylation/demethylation and cancer. Oncotarget 2016;7:67532-50. [PMID: 27556302 DOI: 10.18632/oncotarget.11376] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 14.3] [Reference Citation Analysis]
44 Nair S, Trummell HQ, Rajbhandari R, Thudi NK, Nozell SE, Warram JM, Willey CD, Yang ES, Placzek WJ, Bonner JA, Bredel M. Novel EGFR ectodomain mutations associated with ligand-independent activation and cetuximab resistance in head and neck cancer. PLoS One 2020;15:e0229077. [PMID: 32069320 DOI: 10.1371/journal.pone.0229077] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
45 Cheng CC, Chang J, Huang SC, Lin HC, Ho AS, Lim KH, Chang CC, Huang L, Chang YC, Chang YF, Wu CW. YM155 as an inhibitor of cancer stemness simultaneously inhibits autophosphorylation of epidermal growth factor receptor and G9a-mediated stemness in lung cancer cells. PLoS One 2017;12:e0182149. [PMID: 28787001 DOI: 10.1371/journal.pone.0182149] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
46 Shimomura M, Fukuda T, Awazu Y, Nanno S, Inoue Y, Matsubara H, Yamauchi M, Yasui T, Sumi T. PRMT1 expression predicts response to neoadjuvant chemotherapy for locally advanced uterine cervical cancer. Oncol Lett 2021;21:150. [PMID: 33552268 DOI: 10.3892/ol.2020.12411] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
47 Saloura V, Vougiouklakis T, Sievers C, Burkitt K, Nakamura Y, Hager G, van Waes C. The role of protein methyltransferases as potential novel therapeutic targets in squamous cell carcinoma of the head and neck. Oral Oncol 2018;81:100-8. [PMID: 29884408 DOI: 10.1016/j.oraloncology.2018.04.014] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
48 Picardo F, Romanelli A, Muinelo-Romay L, Mazza T, Fusilli C, Parrella P, Barbazán J, Lopez-López R, Barbano R, De Robertis M, Taffon C, Bordoni V, Agrati C, Costantini M, Ricci F, Graziano P, Maiello E, Muscarella LA, Fazio VM, Poeta ML. Diagnostic and Prognostic Value of B4GALT1 Hypermethylation and Its Clinical Significance as a Novel Circulating Cell-Free DNA Biomarker in Colorectal Cancer. Cancers (Basel) 2019;11:E1598. [PMID: 31635093 DOI: 10.3390/cancers11101598] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
49 Parseghian CM, Napolitano S, Loree JM, Kopetz S. Mechanisms of Innate and Acquired Resistance to Anti-EGFR Therapy: A Review of Current Knowledge with a Focus on Rechallenge Therapies. Clin Cancer Res 2019;25:6899-908. [PMID: 31263029 DOI: 10.1158/1078-0432.CCR-19-0823] [Cited by in Crossref: 26] [Cited by in F6Publishing: 15] [Article Influence: 8.7] [Reference Citation Analysis]
50 Oprita A, Baloi SC, Staicu GA, Alexandru O, Tache DE, Danoiu S, Micu ES, Sevastre AS. Updated Insights on EGFR Signaling Pathways in Glioma. Int J Mol Sci 2021;22:E587. [PMID: 33435537 DOI: 10.3390/ijms22020587] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
51 Westphal M, Maire CL, Lamszus K. EGFR as a Target for Glioblastoma Treatment: An Unfulfilled Promise. CNS Drugs 2017;31:723-35. [PMID: 28791656 DOI: 10.1007/s40263-017-0456-6] [Cited by in Crossref: 81] [Cited by in F6Publishing: 73] [Article Influence: 20.3] [Reference Citation Analysis]
52 Li Z, Wang D, Chen X, Wang W, Wang P, Hou P, Li M, Chu S, Qiao S, Zheng J, Bai J. PRMT1-mediated EZH2 methylation promotes breast cancer cell proliferation and tumorigenesis. Cell Death Dis 2021;12:1080. [PMID: 34775498 DOI: 10.1038/s41419-021-04381-5] [Reference Citation Analysis]
53 Jiang L, Liao J, Liu J, Wei Q, Wang Y. Geranylgeranylacetone promotes human osteosarcoma cell apoptosis by inducing the degradation of PRMT1 through the E3 ubiquitin ligase CHIP. J Cell Mol Med 2021;25:7961-72. [PMID: 34155784 DOI: 10.1111/jcmm.16725] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
54 Zhao J, Adams A, Weinman SA, Tikhanovich I. Hepatocyte PRMT1 protects from alcohol induced liver injury by modulating oxidative stress responses. Sci Rep 2019;9:9111. [PMID: 31235809 DOI: 10.1038/s41598-019-45585-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
55 Wang Q, Shen X, Chen G, Du J. Drug Resistance in Colorectal Cancer: From Mechanism to Clinic. Cancers (Basel) 2022;14:2928. [PMID: 35740594 DOI: 10.3390/cancers14122928] [Reference Citation Analysis]
56 Rugo HS, Jacobs I, Sharma S, Scappaticci F, Paul TA, Jensen-Pergakes K, Malouf GG. The Promise for Histone Methyltransferase Inhibitors for Epigenetic Therapy in Clinical Oncology: A Narrative Review. Adv Ther 2020;37:3059-82. [PMID: 32445185 DOI: 10.1007/s12325-020-01379-x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 16.5] [Reference Citation Analysis]
57 Thiebaut C, Eve L, Poulard C, Le Romancer M. Structure, Activity, and Function of PRMT1. Life (Basel) 2021;11:1147. [PMID: 34833023 DOI: 10.3390/life11111147] [Reference Citation Analysis]
58 Zhao J, O'Neil M, Schonfeld M, Komatz A, Weinman SA, Tikhanovich I. Hepatocellular Protein Arginine Methyltransferase 1 Suppresses Alcohol-Induced Hepatocellular Carcinoma Formation by Inhibition of Inducible Nitric Oxide Synthase. Hepatol Commun 2020;4:790-808. [PMID: 32490317 DOI: 10.1002/hep4.1488] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]